Gene Query: FUCA2

Dataset Description Geneva Score
ChIP-seq and RNA-seq from human lymphoma cell lines 35.9
RNA-seq data from human lymphoma cell lines 35.9
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 32.21
Integrin signaling regulates YAP/TAZ to control skin homeostasis 31.36
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 29.0
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 27.44
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 27.44
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 26.65
WRN knockout effects upon gene expression in SW48 and OVK18 25.43
A role for ZNF598 in post-transcriptional gene regulation 25.1
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 24.82
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 24.82
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 24.64
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 22.86
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 21.63
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 21.58
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 21.54
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 21.45
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 20.78
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 20.71
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 19.79
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 19.3
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 19.26
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 19.03
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 18.53
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 18.53
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 18.5
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 18.49
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 18.38
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 17.77
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 17.77
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 17.59
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 17.25
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 17.15
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 17.15
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 17.11
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 16.97
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 16.63
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 16.62
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 15.69
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 14.6
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 13.74
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 13.57
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 13.57
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 13.38
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 13.38
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 13.37
Mitochondrial dsRNA triggers antiviral signalling in humans 13.17
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 13.08
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 13.08
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 12.89
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 12.73
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 12.71
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 12.66
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 12.47
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 12.45
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 12.22
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 12.11
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 11.98
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 11.89
Solid phase chemistry to covalently and reversibly capture thiolated RNA 11.82
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 11.82
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 11.77
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 11.77
Transcriptomic analysis of the HOTAIR-regulated genes 11.5
Targeting MTHFD2 in Acute Myeloid Leukemia 11.49
Mapping interactions for the TNIP2 hub protein 11.24
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 11.17
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.12
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 11.11
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 11.0
Rorc disruption in human FG pancreatic cancer cells 10.94
Reassessment of Exosome Composition 10.91
FOXD3 is a novel tumor suppressor in lung cancer 10.85
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 10.8
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 10.72
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 10.7
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.66
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 10.59
Spliceosomal disruption of the non-canonical BAF complex in cancer 10.57
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 10.54
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 10.53
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 10.51
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 10.5
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 10.48
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 10.48
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 10.38
Glioblastoma stem cells infected by ZIKA virus 10.37
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 10.37
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 10.27
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.26
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.26
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 10.22
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 10.15
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 10.05
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 10.04
The Genomic Landscape of Atypical Fibroxanthoma 9.89
JAK dependent survival of ALK- ALCL 9.84
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 9.77
AUF-1 affected genes in human skin cells 9.76
Expression profiling of etoposide-induced senescent cells 9.75
RNA expression following TMPRSS11B overexpression or depletion 9.6
Identification of global XBP1s target gene expression in human prostate cancer cells 9.58
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 9.56
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 9.54
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 9.51
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 9.51
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 9.47
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.42
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 9.37
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 9.37
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 9.32
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 9.32
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 9.25
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 9.23
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.16
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 9.06
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 9.03
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 9.03
The role of FAM46C in myeloma cells 9.03
The role of FAM46C in myeloma cells [sequencing] 9.03
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 8.97
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 8.9
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 8.83
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 8.83
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 8.83
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.82
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.82
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.77
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 8.73
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.69
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.67
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 8.67
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.66
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 8.61
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 8.59
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 8.59
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 8.55
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 8.55
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 8.54
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 8.54
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 8.53
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.53
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 8.46
CHD1 regulates cell fate determination by activation of differentiation-induced genes 8.39
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.38
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.36
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 8.33
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 8.28
Global analysis of alternative splicing regulated by RBM10 8.27
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 8.21
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 8.17
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.16
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 8.15
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 8.14
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 8.11
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 8.08
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 8.08
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.08
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 8.06
Co-regulation of splicing by Rbfox1 and hnRNP M 8.06
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 8.05
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.03
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 8.02
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.0
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 8.0
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 8.0
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 7.95
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 7.87
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.85
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 7.84
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.79
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.79
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 7.78
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.69
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.68
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.67
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 7.63
The human blood-nerve barrier transcriptome 7.55
Gene expression changes associated with resistance to tagraxofusp (SL-401) 7.54
Non-coding regions are the main source of tumor-specific antigens [human] 7.52
Non-coding regions are the main source of tumor-specific antigens 7.52
Generation of trichogenic adipose-derived stem cells by expression of three factors 7.47
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 7.47
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 7.46
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 7.46
Developmental stage specific chromosome architecture in human erythroid cells 7.46
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 7.45
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 7.44
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 7.42
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 7.42
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 7.41
Neurofibroma 7.4
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 7.4
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 7.39
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.37
RNA-seq analyses of human prostate cancer cells 7.36
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 7.32
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 7.31
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 7.25
Overexpression of NFIB and YBX1 in MCF-7 cells 7.24
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.24
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 7.24
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 7.21
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 7.17
An RNA-centric dissection of host complexes controlling flavivirus infection 7.17
SRSF1 role in cellular gene expression and splicing 7.16
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 7.14
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 7.13
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 7.12
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 7.12
RNA-seq of cancer cell lines treated with T-025 7.11
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 7.11
Genome-wide discovery of human splicing branchpoints [RNAse] 7.11
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 7.09
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 7.09
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.06
N6-methyladenine DNA Modification in Glioblastoma 7.06
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 7.04
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.04
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.04
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 7.02
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.99
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 6.94
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 6.91
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 6.88
Altering cancer transcriptomes using epigenomic inhibitors 6.88
hnRNP C is a key regulator of protein synthesis in mitosis 6.87
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 6.85
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 6.85
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 6.85
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 6.84
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.84
STRIPAK directs PP2A activity to promote oncogenic transformation 6.84
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 6.84
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 6.82
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 6.82
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 6.8
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.78
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 6.78
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 6.77
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 6.74
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 6.69
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 6.69
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 6.68
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.65
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.65
CD86 regulates a pro-survival signal in myeloma cells 6.64
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 6.62
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.57
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 6.57
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 6.57
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.56
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 6.56
Silencing p300 in MCF7 cells to study expression and alternative splicing 6.55
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.47
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.46
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.46
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 6.43
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 6.31
Identification of HOXB13 target genes responsive to BET inhibitors 6.28
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 6.2
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 6.2
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 6.15
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 6.12
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 6.12
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.1
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.1
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 6.07
The conserved transcriptional landscapes in human spermatogenesis 6.06
RNA-seq of stable and unstable section of human atherosclerotic plaques 6.04
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 6.04
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.02
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 6.01
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.99
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 5.97
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.92
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.87
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 5.82
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 5.82
Transcription elongation regulates genome 3D structure 5.82
iPSC-Derived Cholangiocytes 5.76
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 5.72
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 5.69
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 5.69
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 5.67
Postnatal lipids drive hepatocyte maturation 5.64
ARID1A and ARID1B loss in HCT116 cells 5.5
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 5.46
Androgen Receptor-regulated genes in prostate cancer cells 5.46
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.43
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 5.36
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 5.36
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 5.31
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.31
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 5.29
Functional Haploid Human Oocytes Generated from Polar Body Genomes 5.15
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 5.15
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.1
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.99
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.99
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.92
RNA-seq of RKO cells with cTAZ KO or putback 4.84
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 4.83
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 4.82
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 4.75
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 4.71
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 4.7
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 4.63
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.62
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 4.54
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.48
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.45
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 4.44
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.43
Effect of FGF13 depletion on the H460 cell line 4.43
Hepatocyte maturation 4.37
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.36
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.35
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 4.35
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.34
Gene expressions of H9s in different culture systems 4.33
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.26
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.26
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.25
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.25
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.24
RNA-seq analysis and shRNA screen of breast cancer 4.17
RNA-seq analysis of breast cancer 4.17
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  4.13
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 4.07
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.0
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.0
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.99
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 3.96
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.92
An optimization system for isolating and sequencing of single human colon cancer cells 3.89
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.86
Positively selected enhancer elements endow tumor cells with metastatic competence 3.85
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.81
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.77
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.77
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.76
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 3.69
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 3.69
Transcriptional profile in human S. haematobium infection 3.68
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.67
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 3.67
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 3.65
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 3.6
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 3.57
Identification of a LIF-responsive replication-competent human β cell 3.54
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 3.53
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 3.52
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 3.44
Analysis of transcriptional regulation by Myt1 and Myt1l 3.43
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 3.29
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 3.28
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 3.25
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.23
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.22
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 3.21
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.18
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.18
Profiling of escape kinetics of viruses subjected to RNAi 3.03
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 2.94
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 2.93
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 2.93
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.9
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.9
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 2.89
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.88
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 2.87
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.86
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.85
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.85
RNA editing in nascent RNA affects pre-mRNA splicing 2.8
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.79
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.76
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.74
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.71
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.68
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 2.65
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.64
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.63
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.63
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.6
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.59
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.55
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.46
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 2.44
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.42
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.42
The Glioma-Infiltrating T Cell Receptor Repertoire 2.4
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.4
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.38
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.38
Random mono-allelic expression in MECP2-mutated cells 2.31
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.29
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.28
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 2.28
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.23
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.23
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.21
RNA-seq of CD33 KO and control HSPCs 2.15
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.14
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.11
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.06
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.06
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.98
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.98
Enhancer activation during EGF response 1.96
miR941 overexpression experiment 1.93
Single-cell analysis of human kidney organoids 1.82
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.73
The Genetic Landscape of Diamond-Blackfan Anemia 1.72
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.72
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.68
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.63
Regulation of hypoxia-inducible factor activity by ZMYND8 1.61
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.58
Systematic discovery of endogenous human ribonucleoprotein complexes 1.57
Transposon-based construction of strand-specific RNA-seq libraries 1.56
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.54
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.52
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.48
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.47
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.47
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.36
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.31
Transcriptomes of oxLDL exposed trained monocytes 1.3
oxLDL exposed trained monocytes 1.3
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.3
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.3
Exogenous rescue of KLHL9 in SF210 cell line 1.3
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.29
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.29
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.27
Differential gene expression profiles in imatinib-resistant cell lines 1.27
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.25
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.23
Metabolism as an early predictor of DPSCs aging 1.1
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.1
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.09
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.08
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.08
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.07
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.06
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.05
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.05
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.01
Molecular analysis of renal cell carcinoma with unclassfied histology 1.01
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.99
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.97
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.97
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.94
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.86
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.86
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.82
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.7
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.7
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.65
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.64
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.64
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.64
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.64
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.62
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.61
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.61
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.58
Characterization of human ILC2 subsets 0.57
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.55
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.51
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.48
hNSCs siRNA NOVA2 0.47
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.45
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.44
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.44
Human Treg IL-12 stimulation 0.43
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.35
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.34
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.32
The DPYSL2 gene connects mTOR and schizophrenia 0.31
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.3
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.28
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.24
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.24
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.22
Function and hormonal regulation of GATA3 in human first trimester placentation 0.19
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.19
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.17
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.16
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.15
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.14
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.11
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.04
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.03
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.02
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation